NCT05552482View on ClinicalTrials.gov

Identifying Risk Factors (RF) for Early Haemodialysis Arteriovenous Fistula Failure (eAVFF)

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

October 5, 2021

Study Completion Date

December 21, 2022

Conditions
Arteriovenous FistulaHemodialysisEnd Stage Chronic Renal Failure
Interventions
OTHER

Identification of predictive factors

Evaluation of the following variables : age, sex, body mass index, Diabetes mellitus, vascular disease, hematologic disease, venous thromboembolic disease, antiplatelet or anticoagulant treatments, haemodialysis Catheter Insertion, number of comorbid conditions, Venous diameter, Arterial diameter, AVF type, AVF limb, Anasthesia group

Trial Locations (1)

57085

CHR Metz-Thionville/Hopital de Mercy, Metz

All Listed Sponsors
lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT05552482 - Identifying Risk Factors (RF) for Early Haemodialysis Arteriovenous Fistula Failure (eAVFF) | Biotech Hunter | Biotech Hunter